ArticleJTO clinical and research reports2024

Efficacy and Safety of Dose-Escalated Alectinib in Patients With Metastatic ALK-Positive NSCLC and Central Nervous System Relapse on Standard-Dose Alectinib.

Justin M Cheung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.